secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2024-07-16T23:59:59+00:00
Accession:  0001628280-24-031955
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex appoints James Lee as Interim CFO after Brianna Gerber resignation
----------------------------------------------------------------------------

- Brianna Gerber resigned as CFO and Principal Accounting Officer effective July 12, 2024.
- James Lee, Controller since 2009, appointed Interim CFO and Interim Principal Accounting Officer effective July 13, 2024.
- Gerber will consult on financial and accounting matters through August 12, 2024 under prior agreement.
- Lee holds B.A. in Architecture from UC Berkeley and MBA from UIUC; previously accounting manager at Samsung.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828024031955/0001628280-24-031955-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828024031955/cdxc-20240716.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-031955

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer